The Food and Drug Administration on Friday expanded the approval for GSK’s vaccine to protect against respiratory syncytial virus, or RSV, authorizing its use for
For many Americans, health care means going to a local primary care office. But the vast majority of clinical research is conducted inside the walls
What You Should Know: – Helix, a leader in population genomics, is launching new datasets designed to empower life science companies in developing precision medicine
Data with Bristol Myers Squibb’s Opdivo/Yervoy combination in frontline hepatocellular carcinoma were recently presented at the American Society of Clinical Oncology (ASCO) 2024 Annual meeting.
What You Should Know: – Pediatrics Associates, the leading private pediatric primary care group in the US, has partnered with Innovaccer Inc., a leader in
Dive Brief: The Cybersecurity and Infrastructure Security Agency posted two notices last week regarding vulnerabilities in Baxter products that could allow unauthorized users to compromise
Dive Brief: Abbott said Thursday it has received a CE mark for its dual-chamber leadless pacemaker, clearing the company to start selling the system in
When large swaths of the East Coast were shrouded in wildfire smoke last summer, scientists in California grimly joked that maybe, finally, power brokers in
Long-COVID, also known as post-acute sequelae of SARS-CoV-2 infection, encompasses a range of symptoms that persist even after an individual has seemingly recovered from COVID-19.
Ataxia telangiectasia is a rare, inherited, progressive childhood disorder for which symptoms manifest neurologically and immunologically. Chromadex is developing a candidate to treat ataxia telangiectasia.